US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology Industry Research & Market Reports

4  5  6  7    9    11  12  13  
Biotech Business September 2014
9/1/2014 | published by: Worldwide Videotex
... on biotechnology products and companies. It reports which universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies and their expected growth or decline.  |  read more...
USD 25
Biotech Equipment Update September 2014
9/1/2014 | published by: Worldwide Videotex
Biotech Equipment Update covers news and the latest information about biotechnology lab and manufacturing equipment and products. This includes new product and technology announcements, as well as vendor research, development, and manufacturing information.  |  read more...
USD 25
Scientific Research and Development (R&D) Industry, in Life Sciences, Medical Devices, Biotechnology and Pharmaceuticals (Drugs) Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541711
8/26/2014 | published by: Plunkett Research, Ltd.
... benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Scientific Research and Development (R&D) Industry, in Life Sciences, Medical Devices, Biotechnology and Pharmaceuticals (Drugs) Industry (U.S.) to reach ...  |  read more...
USD 1,995
Discovery Stage Partnering Terms and Agreements
9/1/2014 | published by: Current Partnering
... by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter discovery stage partnering deals. The majority of deals are where the licensee obtains a right ...  |  read more...
USD 3,295
Global Dental Crowns and Bridges Market : 2014-2018
8/27/2014 | published by: TechNavio - Infiniti Research Ltd.
... Market: 3M, Dentsply International, Ivoclar Vivadent AG, Nobel Biocare Holdings AG, Straumann and Zimmer Holdings. Other Prominent Vendors in the market are: BioHorizons, Biomet 3i, Camlog Holding (subsidiary of Henry Schein Canada), GC, Heraeus Holding, ...  |  read more...
USD 2,500
Biotechnology Product Manufacturing
9/1/2014 | published by: First Research, Inc.
... Amgen, Biogen Idec, Genentech (owned by Switzerland-based Roche), and Monsanto, as well as CSL (Australia), Merck KGaA (Germany), Novo Nordisk (Denmark), and the biotech research arms of major international pharmaceutical companies such as Sanofi (France). ...  |  read more...
USD 129
Global Markets for Bioengineered Protein Drugs
8/1/2014 | published by: BCC Research
... grow to about $222.7 billion in 2019, a compound annual growth rate (CAGR) of 7.2% from 2014 through 2019. This report provides: An overview of the global market for bioengineered protein drugs. Analyses of global ...  |  read more...
USD 6,650
Process Liquid Analyzer, Gas Analyzer, and Gas Chromatograph Market by Type (Liquid, Gas), Technology (PH/ORP, Chlorine, Oxygen, Carbon dioxide), Spectroscopy, Gas chromatography, Service, Application (chemical, Pharmaceutical, Power), & Region - Global T
9/2/2014 | published by: MarketsandMarkets
... to 2013 - 2020 A process analyzer is a process analytical instrument that provides chemical composition data on process streams in real-time. It has redefined the way by which companies carry out their production and ...  |  read more...
USD 4,650
Acorda Therapeutics Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... the information you require to better understand Acorda Therapeutics and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up ...  |  read more...
USD 995
Alkermes Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... you require to better understand Alkermes and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal ...  |  read more...
USD 995
Amgen Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying ...  |  read more...
USD 995
Anika Therapeutics Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... the information you require to better understand Anika Therapeutics and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up ...  |  read more...
USD 995
Biogen Idec Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding ...  |  read more...
USD 995
Celgene Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying ...  |  read more...
USD 995
Dendreon Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... you require to better understand Dendreon and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal ...  |  read more...
USD 995
Genentech Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying ...  |  read more...
USD 995
Genmab Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... you require to better understand Genmab and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal ...  |  read more...
USD 995
Genzyme Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying ...  |  read more...
USD 995
Intermune Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... you require to better understand Intermune and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal ...  |  read more...
USD 995
Nektar Therapeutics Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... the information you require to better understand Nektar Therapeutics and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up ...  |  read more...
USD 995
Novartis Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... require to better understand Novartis and its partnering interests and activities over the past five years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and ...  |  read more...
USD 995
Genetic Disorders Partnering Terms and Agreements
8/1/2014 | published by: Current Partnering
... are discovery, preclinical or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. ...  |  read more...
USD 1,995
Marketed Stage Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
... healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals ...  |  read more...
USD 1,495
Clinical Stage Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
... healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals ...  |  read more...
USD 1,495
Discovery Stage Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
... healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals ...  |  read more...
USD 1,495
4  5  6  7    9    11  12  13